Showing results (91-100 of 146) with videos related to
Sort By:
Pageof 15
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 1, 1997
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malariaG Di Perri, P Olliaro, S Nardi, et al.Infection Control and Hospital Epidemiology|February 1, 1993
Transmission of HIV-associated tuberculosis to healthcare workersG Di Perri, G P Cadeo, F Castelli, et al.Journal of Medical Virology|October 21, 2025
The Clinical Presentations of Patients With COVID-19 in the Omicron Era: Missed Opportunities in the Antiviral Treatment of SARS-CoV-2 InfectionsG Bartolucci, E Garro, M Mussa, et al.Acta Neurologica|February 1, 1990
AIDS--associated predominantly sensory neuropathy. The role of herpes virusesS Ferrari, B Bonetti, S Monaco, et al.Journal of Neurovirology|August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patientsA Calcagno, C Atzori, A Romito, et al.Journal of Neurovirology|June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART eraA Calcagno, M C Alberione, A Romito, et al.Infection|November 4, 2011
The effect of inappropriate therapy on bacteremia by ESBL-producing bacteriaF G De Rosa, N Pagani, L Fossati, et al.European Review for Medical and Pharmacological Sciences|November 8, 2018
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensusV Di Marco, A Alberti, G Angarano, et al.Antiviral Research|May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patientsA Calcagno, L Marinaro, S Nozza, et al.The Journal of Infection|March 14, 2000
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapyG Di Perri, S Vento, R Mazzi, et al.Pageof 15